2023
DOI: 10.1016/j.cellsig.2022.110522
|View full text |Cite
|
Sign up to set email alerts
|

Ras suppressor 1 long form (RSU1L) silencing promotes apoptosis in invasive breast cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 33 publications
1
2
0
Order By: Relevance
“…In breast cancer studies, Vasaturo et al [ 24 ] demonstrated that overexpression of RSU1 in Michigan Cancer Foundation-7 (MCF-7) breast cancer cells induced p21 activation and reduced cancer cell proliferation by inhibiting cyclin-dependent kinase, suggesting that RSU1 acts as a tumor suppressor gene in breast cancer, but another study revealed that RSU1 is upregulated at both mRNA and protein levels in more aggressive and highly aggressive MDA-MB-231 breast cancer cells compared to non-invasive MCF-7 breast cancer cells[ 25 ]. Consistent with the above study, Christou et al [ 26 ] reported that high RSU1 expression is associated with poor breast cancer survival. In hepatocellular carcinoma, RSU1 expression has also been found to be elevated in more aggressive HepG2 hepatocellular carcinoma cells compared to non-metastatic Alexander cells[ 13 ], and RSU1 promotes invasion of hepatocellular carcinoma, similar to breast cancer cells.…”
Section: Discussionsupporting
confidence: 79%
“…In breast cancer studies, Vasaturo et al [ 24 ] demonstrated that overexpression of RSU1 in Michigan Cancer Foundation-7 (MCF-7) breast cancer cells induced p21 activation and reduced cancer cell proliferation by inhibiting cyclin-dependent kinase, suggesting that RSU1 acts as a tumor suppressor gene in breast cancer, but another study revealed that RSU1 is upregulated at both mRNA and protein levels in more aggressive and highly aggressive MDA-MB-231 breast cancer cells compared to non-invasive MCF-7 breast cancer cells[ 25 ]. Consistent with the above study, Christou et al [ 26 ] reported that high RSU1 expression is associated with poor breast cancer survival. In hepatocellular carcinoma, RSU1 expression has also been found to be elevated in more aggressive HepG2 hepatocellular carcinoma cells compared to non-metastatic Alexander cells[ 13 ], and RSU1 promotes invasion of hepatocellular carcinoma, similar to breast cancer cells.…”
Section: Discussionsupporting
confidence: 79%
“…Although direct evidence indicating the unique functions of these transcript isoforms in fatty liver disease is limited, some studies related to the transcripts indirectly suggested their possible disease-related roles. For instance, the chicken ENSGALT00010010626 and human ENST00000345264 transcript isoforms of RSU1 might have distinct functions in Ras protein activity because of their additional exon expressions [ 40 ]. When downregulated in fatty liver conditions, these isoforms could contribute to the disease’s characteristics.…”
Section: Discussionmentioning
confidence: 99%
“…Ethanolic extracts were weighted and dissolved in 0.1% Dimethyl Sulfoxide (DMSO) (diluted with PBS) to obtain stock solutions with concentrations ranging from 200-1000 µg/mL. Cell viability following treatment with the plant extracts was assessed using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cell viability assay [23]. Briefly, MDA-MB231, HeLa, SKOV3, HT-29, and HCT-116 cells were seeded in triplicate in 96-well plates at a density of 10 4 cells/well.…”
Section: Mtt Assaymentioning
confidence: 99%